Fidson Healthcare Plc held its Annual General Meeting for FY 2018 on September 26, 2019, at the Banquet Hall, Sheraton Hotels and Towers, Lagos. In keeping with its policy to
Fidson Healthcare Plc (Fidson), one of Nigeria’s leading pharmaceutical manufacturers, hereby announces the execution of a strategic alliance with Ohara Pharmaceutical Co. Ltd (Ohara), a leading Japanese healthcare company. This
According to the Federal Ministry of Health, Nigeria suffers the world’s greatest malaria burden, with approximately 51 million cases and 207,000 deaths reported annually.
For nearly 25 years, Fidson Healthcare Plc is relentlessly pursuing its goal of becoming the dominant player in the pharmaceutical sector in Nigeria. It has built an organizational framework that
Fidson Healthcare Plc recently released its 2018 audited financial report to the Nigerian Stock Exchange, reporting a 15% growth in turnover from N14.06bn in 2017 to N16.23bn in 2018. The
Fidson Healthcare Plc has assured that the company would build on its impressive historic growth and provide investors with good returns in the years ahead. The assurance was given by
Lagos State government has commended Fidson Healthcare Plc for its relentless commitment to the academic development of Nigerian children through the company’s ASTYMIN brand annual flagship programme, Astymin Brilliance Reward.
Riding on the success of previous editions and its impact on children’s academic development and performance in the last eight years, Fidson Healthcare Plc. is set to commence this year’s
The company’s effort in the area of Children’s education can also not go without mentioning. Fidson started its CSR programme with the Children Emergency Relief Foundation (CERF) in 2007 and
“I Thought He Would Die — Mother of congenital heart defect Patient” Mr. and Mrs. Omobowale, parents of baby Israel who was diagnosed with congenital heart defect, went through emotional
